| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/05/2002 | US20020123120 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/05/2002 | US20020123119 Nucleotide sequences coding enzymatic polypeptide for use in screening bactericides and for treatment and prevention of infections |
| 09/05/2002 | US20020123113 Genetically adjusted fluorescent protein for use as detection tool genetic engineering |
| 09/05/2002 | US20020123102 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of thyroid defcets |
| 09/05/2002 | US20020123101 Process for producing peptides by using in vitro transcription/translation system |
| 09/05/2002 | US20020123099 Highly expressible genes |
| 09/05/2002 | US20020123091 Composition for use in the diagnosis, prevention and treatment of cardiovascular, endothelial or angiogenic disorders in mammals |
| 09/05/2002 | US20020123090 Ultrapure vegetable protein materials |
| 09/05/2002 | US20020123075 Detecting modulators of anti-inflammatory activity; obtain cells, incubate with modulator, monitor adjustment in inflammatory activity |
| 09/05/2002 | US20020123067 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 09/05/2002 | US20020123055 Mass spectrometric analysis of biopolymers |
| 09/05/2002 | US20020123047 dexB |
| 09/05/2002 | US20020123044 Diagnosing cancer in humans; obtain biopsy of human tissue, detect and measure signal from bound polypeptide marker, evaluate humans for cancer |
| 09/05/2002 | US20020123039 Peptide for use in the prevention and treatment of vial infections |
| 09/05/2002 | US20020123034 Detecting preferential genetic disorders; obtain cells, transform with vector, recover clones, monitor clone for preferential gene expression, propagate clone expressing preferential genes, monitor killing genes |
| 09/05/2002 | US20020123032 Detection of disease related genes |
| 09/05/2002 | US20020122804 Inhibition of transglutaminase-mediated microbial interaction with a mammalian host |
| 09/05/2002 | US20020122802 Diagnosis and treatment of malignant neoplasms |
| 09/05/2002 | US20020122794 Antigenic preparation for treatment or prevention of helicobacter infection |
| 09/05/2002 | CA2374420A1 Method for producing proteins |
| 09/04/2002 | EP1236800A2 Nucleic acids encoding interferon alpha 2, containing single nucleotide polymorphisms and methods of use thereof |
| 09/04/2002 | EP1235934A2 Screening method for candidate drugs |
| 09/04/2002 | EP1235933A2 Mammalian toxicological response markers |
| 09/04/2002 | EP1235917A1 Compositions and methods utilizing sequences for controlling nucleic acid expression in yeast |
| 09/04/2002 | EP1235907A1 6 human secreted proteins |
| 09/04/2002 | EP1235903A2 Metabollically engineered cells overexpressing pyruvate carboxylase or pyruvate phosphoenolpyruvate carbokylase, and methods to produce and use such cells |
| 09/04/2002 | EP1235860A2 G-protein coupled receptors |
| 09/04/2002 | EP1235859A1 New olfactory receptor polypeptides and dna sequences thereof |
| 09/04/2002 | EP1235847A2 ISOLATION OF FIVE NOVEL GENES CODING FOR NEW Fc RECEPTORS-TYPE MELANOMA INVOLVED IN THE PATHOGENESIS OF LYMPHOMA/MELANOMA |
| 09/04/2002 | EP1235846A1 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 09/04/2002 | EP1235844A1 28 human secreted proteins |
| 09/04/2002 | EP1235843A1 26 human secreted proteins |
| 09/04/2002 | EP1235840A1 Methods for identifying compounds that affect rna/rna binding protein interactions |
| 09/04/2002 | EP1235838A1 23 human secreted proteins |
| 09/04/2002 | EP1235837A1 Kringle domain-containing polynucleotides, polypeptides, and antibodies |
| 09/04/2002 | EP1105508B1 Method for purifying biomolecule or protein complexes |
| 09/04/2002 | EP1068223B1 Calcium salts of lipopeptide antibiotics, method for producing same and their use |
| 09/04/2002 | EP0920447B1 Process of purification of cyclosporin |
| 09/04/2002 | EP0896615B1 Peptide from soluble form of acetylcholinesterase, active as a calcium channel modulator |
| 09/04/2002 | EP0832245B1 Recombinant hexose oxidase, a method of producing same and use of such enzyme |
| 09/04/2002 | EP0764208B1 Bmp-9 compositions |
| 09/04/2002 | EP0755443B1 Tissue-specific enhancer active in prostate |
| 09/04/2002 | EP0711355B1 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors |
| 09/04/2002 | EP0682526B1 PULMONARY ADMINISTRATION OF THE SOLUBLE COMPLEM RECEPTOR TYPE 1 sCR1 |
| 09/04/2002 | EP0636696B1 Process for producing recombinant major histocompatibility antigen class ii protein in microorganisms |
| 09/04/2002 | EP0205475B2 Recombinant methods for production of serine protease inhibitors and dna sequences useful for same |
| 09/04/2002 | CN1367875A Induction method of TH1-like response in vitro |
| 09/04/2002 | CN1367838A Promoters for expressing genes in fungal cell |
| 09/04/2002 | CN1367837A Production of proteins by autoproteolytic cleavage |
| 09/04/2002 | CN1367836A CHP polypeptide as ligand of PAK65 |
| 09/04/2002 | CN1367832A Ehrlichia canis genes and vaccines |
| 09/04/2002 | CN1367831A Use of BNM3 transcriptional activator to control plant embryogenesis and regeneration process |
| 09/04/2002 | CN1367830A Cancer associated antigens and uses therefor |
| 09/04/2002 | CN1367829A Compositions and methods for therapy and diagnosis of lung cancer |
| 09/04/2002 | CN1367790A Moraxella cattarrhalis BASB114 polypeptide antigens and uses thereof |
| 09/04/2002 | CN1367258A Preprartion method of improved hepatoma murine monoclonal antibody |
| 09/04/2002 | CN1367257A Extraction method of chlorella growth factor (chlorella extract and CGF) |
| 09/04/2002 | CN1367180A Novel natural antibacterial peptide, its code sequence and application |
| 09/04/2002 | CN1367179A Novel liver regeneration related protein, its code sequence and application |
| 09/04/2002 | CN1367176A Novel recombinant human tissue factor pathway inhibitor active peptide and its preparation method |
| 09/04/2002 | CN1090238C Process for producing enzyme |
| 09/04/2002 | CN1090237C Granular formulation containing microorganisms, process for preparation and use thereof |
| 09/04/2002 | CA2445692A1 Compositions, methods and systems for the discovery of enediyne natural products |
| 09/04/2002 | CA2444812A1 Compositions, methods and systems for the discovery of enediyne natural products |
| 09/04/2002 | CA2444802A1 Compositions, methods and systems for the discovery of enediyne natural products |
| 09/03/2002 | US6444871 Expression vector for use in the treatment and prevention of viral diseases |
| 09/03/2002 | US6444804 Proteins involved in the synthesis and assembly of core lipopolysaccharide of Pseudomonas aeruginosa |
| 09/03/2002 | US6444803 Bone mineralization proteins, DNA, vectors, expression systems |
| 09/03/2002 | US6444800 Human gastric cancer antigen gene and gastric cancer antigen protein |
| 09/03/2002 | US6444790 Peptidoglycan recognition proteins |
| 09/03/2002 | US6444644 Peptide having specified amino acid sequence; used for inhibition of thromboplastin |
| 09/03/2002 | US6444642 Administering to mammal effective amount of neuregulin polypeptide with p185.sup.erbb2 protein binding activity to stimulate myogenesis of muscle cells |
| 09/03/2002 | US6444468 Treating a sample comprising different double-stranded template polynucleotides wherein said different template polynucleotides contain areas of identity and areas of heterology under conditions which provide for the cleavage of |
| 09/03/2002 | US6444444 Immunogenic composition, comprising at least one nucleic acid fragment as an active component thereof and vector for transformation of a host comprising the nucleic acid fragment |
| 09/03/2002 | US6444438 Method for the preparation of a protein by yeasts using an inducible system, vectors and correspondence transformed strains |
| 09/03/2002 | US6444207 Binding with epitope of antigen; anticancer agents |
| 09/03/2002 | US6444206 Sepsis therapy; monoclonal antibodies |
| 09/03/2002 | CA2105673C Method for production of a vegetable protein hydrolyzate and a use thereof |
| 09/03/2002 | CA2049089C Immunoassay reagents and method for determining cyclosporine |
| 09/03/2002 | CA1341387C Human manganese superoxide dismutase (hmn-sod) |
| 08/29/2002 | WO2002066668A2 Method for producing proteins by fermentation of microorganisms from the thermus family, the protein mixture thus obtained and cosmetic compositions containing same |
| 08/29/2002 | WO2002066650A2 Streptococcus pyogenes polypeptides and corresponding dna fragments |
| 08/29/2002 | WO2002066649A2 ANTI-INTERFERON-α ANTIBODIES |
| 08/29/2002 | WO2002066647A2 Type 2 ctokine receptor and nucleic acids encoding same |
| 08/29/2002 | WO2002066646A2 Neurotransmission-associated proteins |
| 08/29/2002 | WO2002066631A1 Antibodies recognizing helicobacter pylori and method of detecting helicobacter pylori |
| 08/29/2002 | WO2002066630A1 Methods of modifying eukaryotic cells |
| 08/29/2002 | WO2002066628A2 Supersecretable peptides, processes for their production, and parallel improvement of the secreted form of one or more other polypeptides |
| 08/29/2002 | WO2002066618A1 Rapid production of monoclonal antibodies |
| 08/29/2002 | WO2002066603A2 Chemically defined medium for cultured mammalian cells |
| 08/29/2002 | WO2002066514A2 Artificial fusion proteins with reduced immunogenicity |
| 08/29/2002 | WO2002066509A2 Treatment involving dkk-1 or antagonists thereof |
| 08/29/2002 | WO2002066494A2 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade |
| 08/29/2002 | WO2002066058A1 Modified anti-egfr antibodies with reduced immunogenicity |
| 08/29/2002 | WO2002065992A2 A cell therapy method for the treatment of tumors |
| 08/29/2002 | WO2002010388A3 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF |
| 08/29/2002 | WO2001096547A3 Human kinases |
| 08/29/2002 | WO2001085952A3 Modified inosine 5'-monophosphate dehydrogenase polypeptides and uses thereof |
| 08/29/2002 | WO2001079284A3 Therapeutic compounds and methods for formulating v3, a versican isoform |
| 08/29/2002 | WO2001068848A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |